Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Neoplasms 6 Frailty 4 Lymphoma 3 Prostatic Neoplasms 2 Ovarian Neoplasms 2 Head and Neck Neoplasms 2 Fallopian Tube Neoplasms 2 Breast Neoplasms 2 Urinary Bladder Neoplasms 1 Prostate Cancer Cured 1 Neoplasms, Plasma Cell 1 Multiple Myeloma 1 Lung Neoplasms 1 HER2 Positive Breast Carcinoma 1 Colorectal Neoplasms 1

Interventions

Gemcitabine 79 Cisplatin 56 pembrolizumab 32 Paclitaxel 28 Carboplatin 24 Docetaxel 19 Radiotherapy 17 Mitomycin 16 Doxorubicin 15 atezolizumab 14 BCG Vaccine 14 Nivolumab 13 Cystectomy 13 Filgrastim 11 vinflunine 10 Methotrexate 10 Vinblastine 9 Fluorouracil 9 5-aminolevulinic acid hexyl ester 9 Sunitinib 7 Early Intervention, Educational 7 durvalumab 6 avelumab 6 Taxes 6 Methods 6 Cystoscopy 6 Albumin-Bound Paclitaxel 6 enfortumab vedotin 5 Trastuzumab 5 Surveys and Questionnaires 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Urinary Bladder Neoplasms × Geriatric Assessment × Clear all

NCT01776138 2021-10-06

PORCH

UNC Lineberger Comprehensive Cancer Center

Urinary Bladder Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡